News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Drug Development
Neurosearch A/S Shares Fall; Drug Trials Stopped
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
COPENHAGEN -(Dow Jones)- Shares in NeuroSearch A/S (NEUR.KO), one of Denmark's pioneer biotech companies, plummeted 46% Wednesday as a partner declined to proceed with trials of one of the company's most promising drugs.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase III
Boehringer Ingelheim
MORE ON THIS TOPIC
Earnings
Merck Cuts $3B to Support Aggressive Launch Schedule, Late-Stage R&D
July 29, 2025
·
3 min read
·
Annalee Armstrong
Alzheimer’s disease
Roche’s Next-Gen Alzheimer’s Antibody Clears or Reduces Amyloid Plaques in Seven Months
July 28, 2025
·
2 min read
·
Dan Samorodnitsky
Schizophrenia
Atai-Partnered Schizophrenia Drug Flunks Mid-Stage Trial
July 28, 2025
·
2 min read
·
Tristan Manalac
Collaboration
Eli Lilly Commits $856M in Biobucks to Gate Bioscience for New Class of Medicines
July 25, 2025
·
1 min read
·
Dan Samorodnitsky